Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's

NCT: NCT04786106 · ACTIVE_NOT_RECRUITING

NCT IDNCT04786106
StatusACTIVE_NOT_RECRUITING
Start Date2020-12-30
Completion2027-02-15
SponsorCharitable Union for the Research and Education of Peyronie's Disease (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to compare key clinical outcomes of collagenase clostridium histolyticum injections versus surgery for the management of Peyronie's Disease.

Frequently Asked Questions

What is Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's?

Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's is a clinical trial registered under NCT04786106. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04786106?

The current status of NCT04786106 (Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's) is: ACTIVE_NOT_RECRUITING.

When did Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's start?

Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's started on 2020-12-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑